Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420 | ISIN: INE685A01028 | Industry: Pharmaceuticals
| Expensive Performer
3540.4000 4.90 (0.14%)
NSE Sep 17, 2025 14:26 PM
Volume: 126.4K
 

3540.40
0.14%
Motilal Oswal
TRPs sales grew ~25% YoY to INR17.2b (est. India business grew 48.4% YoY to INR6.9b (adj. for GST, growth was ~54%), including the acquisition of Unichem. EBITDA rose 23% YoY to INR3.6b (est. of INR4.1b), with the margin at 21.1% (-20bp YoY, - 310bp QoQ). The QoQ contraction in the margin is mainly due to one-time expense of INR500m, adjusted for which 30 May 2018 the margin stood at ~24%.
Sharekhan decreased Buy price target of Torrent Pharmaceuticals Ltd. to 4024.0 on 29 Aug, 2025.
More from Torrent Pharmaceuticals Ltd.
Recommended